- Home
- VIR vs SVM Comparison
VIR vs SVM Comparison
Compare VIR & SVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- SVM
- Stock Information
- Founded
- VIR 2016
- SVM N/A
- Country
- VIR United States
- SVM Canada
- Employees
- VIR N/A
- SVM N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- SVM Precious Metals
- Sector
- VIR Health Care
- SVM Basic Materials
- Exchange
- VIR Nasdaq
- SVM Nasdaq
- Market Cap
- VIR 706.4M
- SVM 906.7M
- IPO Year
- VIR 2019
- SVM N/A
- Fundamental
- Price
- VIR $5.23
- SVM $5.08
- Analyst Decision
- VIR Strong Buy
- SVM Strong Buy
- Analyst Count
- VIR 8
- SVM 1
- Target Price
- VIR $30.25
- SVM $6.75
- AVG Volume (30 Days)
- VIR 1.2M
- SVM 6.7M
- Earning Date
- VIR 07-31-2025
- SVM 08-12-2025
- Dividend Yield
- VIR N/A
- SVM 0.49%
- EPS Growth
- VIR N/A
- SVM 40.00
- EPS
- VIR N/A
- SVM 0.28
- Revenue
- VIR $20,861,000.00
- SVM $298,895,000.00
- Revenue This Year
- VIR N/A
- SVM $1.10
- Revenue Next Year
- VIR $0.62
- SVM $26.47
- P/E Ratio
- VIR N/A
- SVM $18.13
- Revenue Growth
- VIR N/A
- SVM 38.90
- 52 Week Low
- VIR $4.32
- SVM $2.87
- 52 Week High
- VIR $14.45
- SVM $5.32
- Technical
- Relative Strength Index (RSI)
- VIR 51.12
- SVM 69.49
- Support Level
- VIR $5.20
- SVM $4.45
- Resistance Level
- VIR $6.23
- SVM $5.22
- Average True Range (ATR)
- VIR 0.29
- SVM 0.21
- MACD
- VIR 0.03
- SVM 0.06
- Stochastic Oscillator
- VIR 38.08
- SVM 88.70
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About SVM Silvercorp Metals Inc.
Silvercorp Metals Inc is a mineral exploration company, engaged in the acquisition, exploration, development, and mining of mineral properties. The company's producing mines are located in China, and exploration and development projects are located in China and Ecuador. Its project portfolio comprises the El Domo copper-gold and the Condor gold project in Ecuador. In addition, it operates several silver-lead-zinc mines at the Ying Mining District in Henan Province, China, and the GC silver-lead-zinc mine in Guangdong Province, China. A majority of the company's revenue is generated through the sale of silver concentrates. Its reportable operating segments are the Ying Mining District and GC Mine in China, which derive maximum revenue, and the El Domo and Condor projects in Ecuador.